Allurion announces publication of meta-analysis demonstrating the safety and effectiveness of the allurion program for weight loss

Natick, mass.--(business wire)--allurion technologies, inc. (nyse: alur), a company dedicated to ending obesity, today announced the publication of a systematic review and meta-analysis evaluating the effectiveness and safety of the allurion program. the analysis reviewed studies conducted between 2016 and 2024 and included data from 11 observational studies comprising a total of 2,107 patients. the results of the meta-analysis demonstrated a mean weight reduction of 12.5% and significant reduc.
ALUR Ratings Summary
ALUR Quant Ranking